Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (23)

2024

  1. G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1

    Cell Death and Disease, Vol. 15, Núm. 11

  2. Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

    Archivos de Bronconeumologia, Vol. 60, pp. S67-S76

2023

  1. Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer

    Cancers, Vol. 15, Núm. 12

  2. Circulating proteome for pulmonary nodule malignancy

    Journal of the National Cancer Institute, Vol. 115, Núm. 9, pp. 1060-1070

2021

  1. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2019

  1. CT screening for lung cancer: comparison of three baseline screening protocols

    European Radiology, Vol. 29, Núm. 10, pp. 5217-5226

  2. Tmprss4: A novel tumor prognostic indicator for the stratification of stage ia tumors and a liquid biopsy biomarker for nsclc patients

    Journal of Clinical Medicine, Vol. 8, Núm. 12

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2013

  1. A prognostic DNA methylation signature for stage I non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 31, Núm. 32, pp. 4140-4147

2008

  1. Identification of Importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens

    BMC Molecular Biology, Vol. 9

  2. Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates

    Histology and Histopathology, Vol. 23, Núm. 1, pp. 33-40

2007

  1. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest

    Chest, Vol. 132, Núm. 6, pp. 1932-1938

  2. Computed tomographic screening for lung cancer: Individualising the benefit of the screening

    European Respiratory Journal, Vol. 30, Núm. 5, pp. 843-847

2006

  1. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features

    Cancer Epidemiology Biomarkers and Prevention, Vol. 15, Núm. 2, pp. 373-380

2005

  1. Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 288, Núm. 3 32-3

  2. Early lung cancer detection using spiral computed tomography and positron emission tomography

    American Journal of Respiratory and Critical Care Medicine, Vol. 171, Núm. 12, pp. 1378-1383

2003

  1. Detección precoz del cáncer de pulmón por tomografía computarizada de baja dosis de radiación: Resultados de una muestra de 150 individuos asintomáticos

    Medicina Clinica, Vol. 121, Núm. 2, pp. 41-47

  2. Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury

    American Journal of Respiratory and Critical Care Medicine, Vol. 168, Núm. 3, pp. 287-296

2002

  1. Early detection of lung cancer: The right time

    Medicina Clinica

  2. Early diagnosis or primary prevention in lung cancer (multiple letters) [1]

    Medicina Clinica